We investigated the effects of dietary α-tocopherol and polyunsaturated fatty acids (PUFA) on ischemia-reperfusion injury and cardiac lipid composition. Rats were fed corn oil (CO) diets either deficient (CO - E) or supplemented (CO + E) with RRR-α-tocopherol (100 IU kg-1 diet), or butter oil (BO) diets either deficient (BO - E) or supplemented (BO + E) with RRR-α-tocopherol (100 IU kg-1 diet). Intact rat hearts were subjected to ischemia before reperfusion. Dietary RRR-α-tocopherol supplementation contributed to recovery of aortic output, cardiac output and diastolic pressure after ischemia-reperfusion. In contrast, the type of dietary fat did not influence most measures of cardiac recovery. RRR-α-tocopherol levels in cardiac tissues and plasma were significantly higher for rats fed the BO + E diet than for rats fed the CO + E diet. In contrast to plasma, PUFA in cardiac tissues were maintained at a high level even when rats were fed BO containing diets. Our results suggest that dietary RRR-α-tocopherol, but not dietary PUFA levels, modulate oxidative damage to intact rat hearts during ischemia-reperfusion.

京都大学 / 0048 / 新制・課程博士 / 博士(農学) / 甲第19021号 / 農博第2099号 / 新制||農||1030(附属図書館) / 学位論文||H27||N4903(農学部図書室) / 31972 / 京都大学大学院農学研究科応用生物科学専攻 / (主査)教授 久米 新一, 教授 祝前 博明, 教授 廣岡 博之 / 学位規則第4条第1項該当 / Doctor of Agricultural Science / Kyoto University / DFAM

Seasonally high nighttime temperatures (HNT) along the United States Gulf Coast and in regions of similar climate, during the critical stages of development, could reduce rice yield and quality. To study the effects of HNT on plant physiology, a method for applying a controlled heating treatment to plant canopies was developed using overhead infrared heaters, which are relatively inexpensive and are accurate, precise and reliable in rapidly controlling the temperature. The apparatus successfully maintained air temperatures within the set points plus/minus 0.5 degrees C, and was used for all the experiments. Several experiments were conducted to determine the response of various physiological parameters during and following exposure of rice plants to HNT (32 degrees C) or ambient nighttime temperature (ANT) (27 degrees C) starting from 2000 h until 0600 h, and with or without plant growth regulator treatments. The plant growth regulator treatments included alpha-tocopherol (vitamin E), glycine betaine (GB), and salicylic acid (SA), which play different roles in inducing thermo-tolerance in plants. High nighttime temperature had no effect on plant height, number of tillers and panicles, or rice net leaf photosynthetic rates. However, HNT increased leaf respiration (dark respiration in the night) (21%) and decreased membrane thermo-stability (60%), pollen germination (20%), spikelet fertility (18% as a % of total spikelets), grain length (2%), and grain width (2%). The HNT also hastened plant development. The combinations of these effects decreased rice yield by 90%. Moreover, under HNT, there were decreases in leaf chlorophyll concentration (7%) and nitrogen concentration (18%). Application of GB and SA increased total antioxidant capacity of the rice plants by 17%, thereby decreasing the leaf respiration rates, increasing membrane thermo-stability, pollen germination, and spikelet fertility, thus increasing the yield. High nighttime temperature decreased leaf starch concentration (14%), grain total nonstructural carbohydrate (TNC) concentration (9%), and grain extractable invertase activity (20%). Vitamin E- or GB-treated plants had greater grain soluble-sugar concentrations, whereas SA-treated plants had greater leaf soluble-sugar concentrations and lower grain TNC concentrations. Invertase activity was shown to be not rate limiting or required for sucrose degradation for starch synthesis in grain of 'Cocodrie' rice under short-term high nighttime temperatures exposures during grain filling. In conclusion, HNT decreased rice yield by increasing plant respiration, rate of crop development, and decreasing membrane thermo-stability, pollen germination, spikelet fertility and grain dimensions. Exogenous application of GB and SA increased yields under HNT, possibly acting through increased antioxidant levels, which might have protected the membranes and enzymes against heat-induced ROS-mediated degradation.

Einleitung Adipositas ist ein zunehmendes Problem bei Menschen und Haustieren, z.B. in Pferden. Ponyrassen sind dabei besonders prädisponiert, wobei die Gründe bisher nicht abschließend geklärt werden konnten. Humane Adipositas geht mit einer fettigen Infiltration der Leber einher, die sogenannte Non-Alcoholic Fatty Liver Disease, welche zu einer hepatozellulären Entzündung führt. Es ist bisher nicht bekannt, ob Adipositas in Equiden auch zu hepatischen Veränderungen führt. Menschliche Fettleibigkeit ist zusätzlich mit systemischer Entzündung und gesteigertem oxidativen Stress verbunden. Das führte zu intensiven Untersuchungen von anti-inflammatorischen und antioxidativen Faktoren (z.B. Vitamin A - Retinol und Vitamin E - α-Tocopherol) in der humanen Adipositas Forschung. Viele Studien konnten ein Absinken von Vitamin A und Vitamin E in fettleibigen Menschen feststellen. Ziele Die vorliegende Studie sollte den Einfluss von zunehmendem Körpergewicht (KG) in Ponys und Pferden auf mehrere Parameter untersuchen: (1) Serum Leberenzymaktivitäten und Serum Gallensäuren (GS), (2) Leberfettgehalt, (3) hepatische messenger Ribonukleinsäure (mRNA) Level von Entzündungsmarkern und Markern des Lipidmetabolismus und (4) Serum Konzentrationen von Retinol und α-Tocopherol. Zusätzlich sollten Ponys und Pferde im Verlauf dieser Studie verglichen werden, um eventuelle Gründe für die Rasseprädisposition der Ponys für metabolische Störungen zu identifizieren. Material und Methoden Zehn Shetland Ponys und 9 Warmblut Pferde, die initial nicht adipös waren, wurden über 2 Jahre mit 200% des Erhaltungsbedarfes für umsetzbare Energie gefüttert. Die Entwicklung des KG, des Body Condition Scores (BCS) und des Cresty Neck Scores (CNS) wurde wöchentlich erfasst. Während der Fütterungsphase wurde zu 6 Zeitpunkten (ZP) Blut für die Bestimmung von Serum Leberenzymaktivitäten (Alkaline Phosphatase (ALP), Aspartat Aminotransferase (AST), Glutamat Dehydrogenase (GLDH), Gamma-Glutamyl Transferase (GGT)) und Serum GS entnommen und zu 7 ZP wurde Blut für die Analyse von Serum Retinol und α-Tocopherol gewonnen. An 3 ZP wurde durch Laparotomie Lebergewebe in Vollnarkose entnommen. Die Leberbiopsien wurden histologisch auf ihren Fettgehalt untersucht und mittels quantitativer Echtzeit Polymerase-Kettenreaktion (RT-qPCR) wurden die mRNA Level von Entzündungsmarkern (Nuclear Factor-κB (NF-κB), Interleukin-1β (IL-1β), IL-6, Tumor Nekrose Faktor α (TNFα), Differenzierungsgruppe 68 (CD68), Chemerin) und Lipid Metabolismus Markern (Lipoprotein Lipase (LPL), Fettsäuren Bindungsprotein 1 (FABP1) bestimmt. Die Daten wurden mittels statistischem Software Programm ausgewertet (STATISTICA, version 12, StatSoft GmbH, Hamburg, Deutschland). Nach Prüfung auf Normalverteilung der Daten, wurden geeignete statistische Tests angewendet mit einem statistischen Signifikanzniveau bei P < 0,05. Die Tierschutzkommission des Bezirks Leipzig genehmigte das Projekt in Übereinstimmung mit deutschen Rechtsvorschriften (Nr. TVV 32/15). Ergebnisse Ponys und Pferde zeigten einen signifikanten Anstieg von KG (Mittelwert ± SD; Ponys: 29,9 ± 19,4%; Pferde: 17 ± 6,74%), BCS (Median (25./75. Perzentil); Ponys: 157% (115/349); Pferde: 142% (128/192)) und CNS (Median (25./75. Perzentil); Ponys: 165% (123/500); Pferde: 200% (160/225)) induziert durch die hyperkalorische Fütterung über 2 Jahre. Das ansteigende KG hat keine Steatosis in der Mehrheit der Equiden ausgelöst. Die mRNA Level von IL-6, TNFα, CD68 und IL-1β in der Leber wurden nicht beeinflusst. Die Leber mRNA Level von Chemerin sind signifikant angestiegen in Ponys (x-facher Anstieg: 1,89) und Pferden (x-facher Anstieg: 2,04). Signifikante Unterschiede zwischen den Rassen hinsichtlich der Serum GLDH Aktivitäten, Serum GS Konzentrationen und der hepatischen mRNA LPL Level konnten festgestellt werden. Die Serum α-Tocopherol Konzentrationen stiegen in Ponys und Pferden signifikant an und korrelierten positiv mit der Vitamin E Aufnahme. Die Serum Retinol Konzentrationen fluktuierten während der Studie, ohne mit der Aufnahme zu korrelieren. Schlussfolgerungen Frühe Fettleibigkeit in Equiden führt nicht zwangsläufig zu einer Steatose mit hepatozellulärer Entzündung. Gemäß der Hypothese zeigten Ponys und Pferde allerdings unterschiedliche hepatische Reaktionsmuster nach KG Zunahme. Das könnte die höhere Empfänglichkeit von Ponys für metabolische Erkrankungen erklären. Chemerin konnte als interessanter Marker für die equine Adipositas Forschung identifiziert werden. Serum Konzentrationen von Retinol und α-Tocopherol wurden durch die KG Zunahme nicht beeinflusst.

BACKGROUND: α-tocopherol (AT) and γ-tocotrienol (GT3) are vitamin E isoforms considered to have potential chemopreventive properties. AT has been widely studied in vitro and in clinical trials with mixed results. The latest clinical study (SELECT trial) tested AT in prostate cancer patients, determined that AT provided no benefit, and could promote cancer. Conversely, GT3 has shown antineoplastic properties in several in vitro studies, with no clinical studies published to date. GT3 causes apoptosis via upregulation of the JNK pathway; however, inhibition results in a partial block of cell death. We compared side by side the mechanistic differences in these cells in response to AT and GT3. METHODS: The effects of GT3 and AT were studied on androgen sensitive LNCaP and androgen independent PC-3 prostate cancer cells. Their cytotoxic effects were analyzed via MTT and confirmed by metabolic assays measuring ATP. Cellular pathways were studied by immunoblot. Quantitative analysis and the determination of relationships between cell signaling events were analyzed for both agents tested. Non-cancerous prostate RWPE-1 cells were also included as a control. RESULTS: The RAF/RAS/ERK pathway was significantly activated by GT3 in LNCaP and PC-3 cells but not by AT. This activation is essential for the apoptotic affect by GT3 as demonstrated the complete inhibition of apoptosis by MEK1 inhibitor U0126. Phospho-c-JUN was upregulated by GT3 but not AT. No changes were observed on AKT for either agent, and no release of cytochrome c into the cytoplasm was detected. Caspases 9 and 3 were efficiently activated by GT3 on both cell lines irrespective of androgen sensitivity, but not in cells dosed with AT. Cell viability of non-cancerous RWPE-1 cells was affected neither by GT3 nor AT. CONCLUSIONS: c-JUN is a recognized master regulator of apoptosis as shown previously in prostate cancer. However, the mechanism of action of GT3 in these cells also include a significant activation of ERK which is essential for the apoptotic effect of GT3. The activation of both, ERK and c-JUN, is required for apoptosis and may suggest a relevant step in ensuring circumvention of mechanisms of resistance related to the constitutive activation of MEK1.

Nutritional factors play an important role in the prevention and promotion of colorectal cancer. Vitamin E is a generic term that describes a group of lipid-soluble chain-breaking antioxidants that includes tocopherols and tocotrienols. Vitamin E occurs in nature as eight structurally related forms that include four tocopherols and four tocotrienols. Vitamin E is a potent membrane-soluble antioxidant. Antioxidants like vitamin E (tocopherols) may prevent colon cancer through several different cellular and molecular mechanisms. Vitamin E in the American diet is primarily available in plant-oil rich foods such as vegetable oils, seeds and nuts and these foods vary widely in their content of α-tocopherol and γ-tocopherol [1]. Vitamin E may help prevent colon cancer by decreasing the formation of mutagens arising from the oxidation of fecal lipids, by decreasing oxidative stress in the epithelial cells of the colon and by molecular mechanisms that influence cell death, cell cycle and transcriptional events. Most epidemiological, experimental and clinical studies have evaluated the α-isoform and not the γ-isoform of vitamin E. Recent epidemiological, experimental and mechanistic evidence suggests that γ-tocopherol may be a more potent cancer chemopreventive agent than α-tocopherol. The differences in chemical reactivity, metabolism and biological activity may contribute to these differences in the effects of γ-tocopherol when compared with α-tocopherol. The rationale supporting the development of γ-tocopherol as a colorectal cancer preventive agent is reviewed here.

This review will focus on the therapeutic uses of antioxidant liposomes. Antioxidant liposomes have a unique ability to deliver both lipid- and water-soluble antioxidants to tissues. This review will detail the varieties of antioxidants which have been incorporated into liposomes, their modes of administration, and the clinical conditions in which antioxidant liposomes could play an important therapeutic role. Antioxidant liposomes should be particularly useful for treating diseases or conditions in which oxidative stress plays a significant pathophysiological role because this technology has been shown to suppress oxidative stress. These diseases and conditions include cancer, trauma, irradiation, retinotherapy or prematurity, respiratory distress syndrome, chemical weapon exposure, and pulmonary infections.

The purpose of this investigation was to determine how dietary levels of α-tocopherol, γ-tocopherol and iron influence oxidative stress and ras-p21 levels in the colon. Rats were fed diets deficient in tocopherols (-E) or supplemented with either 0.156 mmol of α-tocopherol (AE)/kg diet or 0.156 mmol of γ-tocopherol (GE)/kg of diet. Half the rats in each of these three groups received dietary iron at a level of 35 mg/kg diet and the other half at eight times this level (280 mg/kg diet). Rats fed the AE diets had higher levels of Vitamin E in feces, colonocytes, plasma and liver than did rats fed the GE diets. Dietary iron levels did not influence tocopherol levels in plasma, liver or feces. For colonocytes, high dietary iron decreased tocopherol levels. The ratio of γ-tocopherol (in the GE groups) to α-tocopherol (in the AE groups) was 0.13 for plasma, 0.11 for liver, 0.28 for colonocytes and 0.51 for feces. The plasma ratio is not, therefore, predictive of the ratio in colonocytes and feces. High levels of dietary iron increased levels of fecal lipid hydroperoxides. Moreover, rats fed the GE diets had lower levels of fecal lipid hydroperoxides than rats fed the AE diets. The levels of ras-p21 were significantly lower in rats fed the GE diets compared with rats fed the AE diets. The γ-tocopherol may, therefore, play a significant role in preventing colon cancer. High levels of dietary iron were found to promote oxidative stress in feces and colonocytes.

With use of deuterium-labeled isotopes of RRR-and all-rac-α-tocopheryl acetate, the transport of vitamin E in pregnancy was evaluated to determine whether the placenta discriminates between these compounds. Fifteen pregnant subjects were recruited 5 d before delivery to receive 15, 30, 75, 150, or 300 mg vitamin E/d in capsules containing d3-RRR-α-tocopheryl acetate and d6-all-rac-α-tocopheryl acetate (1:1, by wt). Maternal blood was obtained before dosing, at hospital admission, and at parturition. Cord blood samples were obtained at parturition. Deuterium-labeled and unlabeled tocopherol contents were determined by gas chromatography-mass spectrometry in plasma and lipoproteins (chylomicrons, VLDL, LDL, and HDL). Maternal plasma and lipoproteins obtained at delivery had higher concentrations of d3-RRR-α- tocopherol than d6-all-rac-α-tocopherol regardless of the vitamin E dose administered (P < 0.05). Cord plasma at delivery also had higher concentrations of d3-RRR-α-tocopherol than d6-all-rac-α-tocopherol in plasma irrespective of the dose administered (P < 0.05). In lipoproteins isolated from cord blood, tocopherol concentrations were greatest in the HDL fraction (P < 0.05), whereas in maternal blood they were greatest in the LDL fraction (P < 0.05). We conclude that the placental-fetal unit, the fetal liver, or both further discriminate between RRR- and all-rac-α-tocopherol.

Phospholipids, such as phosphatidylserine (PS) have been shown to work synergistically with tocopherols to extend the shelf life of oil-in-water emulsions. However, the high cost of PS prevents it from being used as a food additive. This work investigated the potential use of a high PS enzyme-modified lecithin to be used along with α-tocopherol to extend the lag phase of oil-in-water emulsions stabilized using Tween 20. Phospholipase D from Streptomyces sp. and L-serine were used to modify lecithin to increase PS concentration. Enzyme activity was optimized as a function of pH and temperature using a high PC soybean lecithin. The high PS modified lecithin was examined for its ability to enhance the activity of α-tocopherol in Tween 20-stabilized oil-in-water emulsions. The modification was also performed in high PC sunflower lecithin and egg lecithin which were later analyzed for their efficiency in controlling lipid oxidation. α-Tocopherol (3.0 µmol/kg emulsion) alone increased the lag phase of hydroperoxide and hexanal lag phases by 3 and 4 days compared to the control. Authentic PS (15.0 µmol/kg emulsion) increased hydroperoxide and hexanal lag phases by 1 and 3 days, respectively, whereas high PS soy lecithin increased hydroperoxide and hexanal lag phases by 3 and 4 days, respectively. The addition of high PS sunflower and egg lecithin did not have any considerable effects on lag phases compared to the control. Authentic PS (15.0 µmol/kg emulsion) and a-tocopherol (3.0 µmol/kg emulsion) decreased lipid oxidation by increasing the hydroperoxide and hexanal lag phase to 6 and 9 days. The combination of phospholipase D modified high PS lecithins (15.0 µmol/kg emulsion) and a-tocopherol (3.0 µmol/kg emulsion) were able to synergistically increase the antioxidant activity of a-tocopherol increasing the hydroperoxide and hexanal lag phase by 6 and 9 days for soy, 5 days, and 7 days for sunflower and 4 and 6 days for egg lecithin, respectively. This resulted in synergistic antioxidant activity (interaction index > 1.0) except for a-tocopherol and high PS Egg lecithin which showed an additive effect. This research shows that the combination of enzyme-modified high PS lecithin and α-tocopherol could be an effective and commercially viable clean label antioxidant strategy to control lipid oxidation in emulsions.